High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors

被引:45
|
作者
Majhail, Navneet S. [1 ]
DeFor, Todd [1 ]
Lazarus, Hillard M. [2 ]
Burns, Linda J. [1 ]
机构
[1] Univ Minnesota, Blood & Marrow Transplant Program, Minneapolis, MN USA
[2] Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA
关键词
allogeneic stem cell transplantation; iron overload; late complications; ferritin; liver iron concentration;
D O I
10.1016/j.bbmt.2008.04.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic hematopoietic cell transplant (HCT) recipients frequently need red blood cell transfusions, and can be at risk for developing iron overload. We studied the prevalence of iron overload in 56 adult allogeneic HCT patients who had survived for a median of 28 (range: 12-151) months from transplant. Patients were initially screened with serum ferritin, and those with serum ferritin >1000 ng/mL underwent R2 magnetic resonance imaging (MRI) of the liver, a sensitive and specific noninvasive imaging technique to measure liver iron concentration (LIC). Iron overload was defined as LIC above normal (>1.8 mg/g dry weight). Nineteen patients had serum ferritin >1000 ng/mL with a median LIC of 7.0 (range: 1.8-28.3) mg/g. The overall prevalence of iron overload was 32% (95% confidence intervals, 20%-46%). The LIC on AM was moderately correlated with serum ferritin (p = .47). Iron overload is a frequent complication of allogeneic transplantation. Serum ferritin is a good screening test but does not reliably predict tissue iron overload, and estimation of LIC should be considered before initiating therapy. More studies are needed to determine the impact of iron overload on long-term morbidity and mortality in allogeneic transplant survivors. (C) 2008 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:790 / 794
页数:5
相关论文
共 50 条
  • [41] Evaluation of Post-Transplant Iron Chelation Therapy in Allogeneic Hematopoietic Stem Cell Transplant
    Aziz, May
    Gregory, Kelly
    Corrigan, Patricia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S376 - S376
  • [42] Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant
    Rotz, Seth J.
    Ryan, Thomas D.
    Hlavaty, Joel
    George, Stephen A.
    El-Bietar, Javier
    Dandoy, Christopher E.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [43] Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation
    Seneviratne, Ayesh K.
    Wright, Clare
    Lam, Wilson
    Lipton, Jeffrey H.
    Michelis, Fotios V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 241 - 249
  • [44] Post-Transplant Work Status of Young Adult Survivors of Allogeneic Hematopoietic Cell Transplant: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)
    Bhatt, Neel S.
    Brazauskas, Ruta
    Bo-Subait, Stephanie
    Salit, Rachel B.
    Syrjala, Karen
    Tecca, Heather R.
    Battiwalla, Minoo
    Buchbinder, David K.
    Hamilton, Betty K.
    Phelan, Rachel
    Shaw, Bronwen E.
    BLOOD, 2019, 134
  • [45] Effects of iron chelation therapy on allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome patients with iron overload
    顾彩红
    China Medical Abstracts (Internal Medicine), 2016, 33 (02) : 54 - 55
  • [46] RELATION OF IRON OVERLOAD WITH THE PATTERN OF IMMUNE RECONSTITUTION AND THE DEVELOPMENT OF FUNGAL INFECTIONS AFTER ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS
    Munoz-Ballester, J.
    Chen-Liang, T. H.
    Hurtado, A. M.
    Iniesta, P.
    Nieto Jose, B.
    Lopez-Godino, O.
    De Arriba, F.
    Garcia-Malo, M. D.
    Ortuno, F. J.
    Heras, I
    Vicente, V.
    Castilla-Llorente, C.
    Jerez, A.
    HAEMATOLOGICA, 2015, 100 : 214 - 214
  • [47] Iron overload is a frequent hidden complication after allogeneic hematopoietic cell transplantation and treatable by phlebotomy
    Eisfeld, A
    Krahl, R
    Burkhardt, R
    Otto, S
    Edel, E
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 2005, 35 : S62 - S63
  • [48] Returning to employment following allogeneic hematopoietic stem cell transplant: A major problem among survivors
    Filgueira, Luis
    Steinberg, Amir
    Mendonca, Rochelle
    Lim, Seah H.
    EJHAEM, 2023, 4 (04): : 1132 - 1142
  • [49] What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    C A Clark
    M Savani
    M Mohty
    B N Savani
    Bone Marrow Transplantation, 2016, 51 : 1025 - 1031
  • [50] Lifelong follow-up in adult allogeneic hematopoietic cell transplant survivors: a pilot single center initiative improving data registration
    Luyten, K.
    Van Hulle, J.
    Wynants, K.
    Van Ham, J.
    Cleeren, M.
    Maertens, J.
    Beckers, M.
    Schoemans, H.
    Goris, K.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 431 - 432